Stock AZTR AZITRA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Azitra, Inc.

Equities

AZTR

US05479L1044

Delayed Nyse
Other stock markets
 02:06:58 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.1962 USD +0.72% Intraday chart for Azitra, Inc. +11.54% -78.67%
May. 10 Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting CI
May. 09 Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
AQ
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
AQ
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
CI
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
CI
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
BU
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
BU
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Azitra Closes $5 Million Public Offering
MT
Azitra, Inc. Announces Closing of Public Offering
BU
Top Midday Decliners
MT
Azitra Prices Stock Offering at $0.30 a Share
MT
Azitra, Inc. Announces Pricing of Public Offering
BU
Azitra Launches Common Stock Offering; Shares Drop
MT
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US
BU
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AZTR Stock
  4. News Azitra, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW